[1]
“COMPARISON OF PLASMA COAGULABILITY AFTER SHORT-TERM TREATMENT WITH ROSUVASTATIN VERSUS ATORVASTATIN IN UNSTABLE ANGINA PATIENTS”, RS Global - World Science, no. 7(59), Sep. 2020, doi: 10.31435/rsglobal_ws/30092020/7202.